Pharmaceutical Commerce

JUNE 17, 2025

Structuring patient assistance programs as independent non-profit foundations helps pharmaceutical companies reduce regulatory and legal exposure while allowing for more holistic, patient-centered support. Lastly, PAPs that are directly managed by pharmaceutical companies may also struggle with public image issues.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing Pharmaceutical Manufacturing 59

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores 59

Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

JANUARY 16, 2023

This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. Free Report.

Drug Pricing 64

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 64

Pharmaceutical Commerce

JUNE 17, 2025

AI in value-based pricing and RWE generation AI has the potential to transform value-based pricing (VBP) by leveraging machine learning for dynamic pricing models that adjust drug prices based on real-world patient outcomes.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

Pharmaceutical Technology

JUNE 6, 2025

In one of the fierier remarks from the roundtable, RFK Jr said: “At every level, doctors, other providers, our hospitals, the pharmaceutical companies, the insurance companies, all make money by keeping us sick. We need to fundamentally change that so that we are focusing on curing disease and making people better.”

Insurance Coverage and Processing 81

Insurance Coverage and Processing Communication Hospitals Drug Development 81

Pharmaceutical Technology

JANUARY 16, 2023

This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. Free Report.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

PharmaVoice

JUNE 16, 2025

The industry is awaiting guidance on a rebate approach to the contentious drug discount program for hospitals and aiming for tighter oversight. The 340B Drug Pricing Program has long been a contentious issue for pharma. Please let us know if you have feedback.

Hospitals 214

Hospitals Mail-Order Pharmacies Drug Pricing Pharmaceutical Companies 214

PharmaState Academy

MARCH 6, 2024

This quiz competition is brought to you by Pharma Industry Townhall – Sales & Marketing scheduled for 16th March 2024 at Radisson Blue, Marol, Andheri East, Mumbai. a) Medical Research b) Marketing Representative c) Medication Review d) Market Regulation MR' commonly refers to Marketing Representative in pharmaceutical marketing.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

MAY 11, 2025

accelerates its crackdown on drug pricing through new legislation and regulatory enforcement, pharma companies in China, India, Japan, and South Korea are feeling the ripple effect. This article explores whats behind the sudden slump in Asian pharmaceutical equities and why U.S. As the U.S. Table of Contents The U.S.

Drug Pricing 59

Drug Pricing Biosimilars Communication Immunization 59

STAT

APRIL 23, 2025

… Four months ago, a small pharmaceuticals company bought a medicine used to combat a rare growth disorder in children and quickly raised the list price by 150% , STAT says. European pharmaceutical bosses have called on the European Union to increase drug prices toward the much higher levels paid by the U.S.,

Compounding 173

Compounding Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 173

STAT

JANUARY 11, 2024

WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare to negotiate prescription drug prices, will soon face their first big tests. Continue to STAT+ to read the full story…

Drug Pricing 323

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 323

BioPharma Dive

JUNE 24, 2025

Editors picks George Frey/Reuters Deep Dive A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology Over the past 10 years, PD1-blocking medicines have transformed cancer care. 4, 2024 Permission granted by Bristol Myers Squibb Deep Dive // Brain drug revival Psychiatry drugs finally have pharma’s attention.

Drug Pricing 87

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Packaging 87

Pharmaceutical Commerce

JUNE 18, 2025

How Recent Executive Orders Impact the Drug Pricing Landscape Nicholas Saraceno, Editor May 30th 2025 Podcast Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Pharmacy Technician Pharmaceutical Companies 52

Pharmaceutical Commerce

JUNE 16, 2025

It’s an understatement to say there’s a lot going on right now that could impact pharmaceutical companies’ and drug brands’ patient access strategies. With pricing, Medicare frameworks, pharmacy benefit manager rebates, and more seemingly up for redesign, it would be hard not to fixate on regulatory uncertainty.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 2, 2025

The government therefore is advocating for the creation of the new drug regulatory agency to expedite economic growth, streamline drug approvals and attract international pharmaceutical companies to invest in the country. How will RFK Jr’s American dream for vaccines play out?

Packaging 52

Packaging Drug Pricing Communication Hospitals 52

Pharmaceutical Technology

JULY 10, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E. How will RFK Jr’s American dream for vaccines play out? Credit: Zentiva Group, a.s. The partnership will enhance the availability of the affordable biosimilar on a global scale.

Biosimilars 52

Biosimilars Packaging Hospitals Communication 52

Pharmaceutical Technology

JULY 10, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E. How will RFK Jr’s American dream for vaccines play out? From ADCs to TPDs, targeted therapies are transforming the treatment landscape for complex diseases. You will receive an email shortly. You will receive an email shortly.

Packaging 52

Packaging Communication Pharmaceutical Companies Pharmaceutical Companies 52

Viseven

MAY 9, 2025

Role of HEOR in Pharmaceutical Industry With budget constraints tightening and drug prices facing greater scrutiny, Health Economics and Outcomes Research has become a cornerstone of modern pharmaceutical strategy. How Does the HEOR Model Work for Pharmaceutical Companies?

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

STAT

JULY 6, 2023

Advertisements eviscerating and glorifying pharmacy benefit managers have been around for years, but have intensified over the past three months as Congress scrutinizes the role these middlemen play in shaping high prescription drug prices , STAT tells us. The company hopes to launch the product in the U.S. in 2024.

Drug Pricing 181

Drug Pricing Vaccines Diabetes Pharmaceutical Companies 181

Pharmaceutical Technology

SEPTEMBER 26, 2022

Sandoz has faced and may in the future face strong competition from other generic and biosimilar pharmaceutical companies, which aggressively compete for market share, including through significant price competition. The company had revenues of $9.6bn both in 2020 and last year. The site employs around 250 people.

Biosimilars 64

Biosimilars Drug Development Vaccines Dosage 64

Pharmaceutical Commerce

JUNE 9, 2025

Over the past couple years, the demand for this RSV vaccine has continued to be high; in fact, Sanofi had announced in October 2023 that the extraordinary demand had caused shortages impacting the 2023-2024 season. February 2, 2024. 2 The CDC did not revise any recommendations for the 50 mg doses at that time. June 9, 2025.

Drug Pricing 52

Drug Pricing Vaccines Immunization Immunity 52

STAT

OCTOBER 22, 2024

” The remarks reiterate concerns raised by health policy and law experts that partnerships between pharma and telehealth companies could increase prescribing of unnecessary and expensive medications.  But of the six executives who donated to individual candidates between July 1 and Sept.

Online Pharmacies 223

Online Pharmacies Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 223

pharmaphorum

JUNE 18, 2025

Skip to main content Wednesday 18 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Diabetes 88

Diabetes Pharmaceutical Companies Pharmaceutical Companies Immunization 88

STAT

NOVEMBER 11, 2024

that is distrustful of institutions and eager to blame large corporations, including major pharmaceutical companies, for Americans’ poor health. Kennedy Jr. Insurers could be squeezed if Democrat-passed subsidies to Affordable Care Act plans expire, driving people out of the market.

Hospitals 340

Hospitals Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 340

BioPharma Dive

JUNE 30, 2025

Editors picks George Frey/Reuters Deep Dive A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology Over the past 10 years, PD1-blocking medicines have transformed cancer care. 4, 2024 Adeline Kon/BioPharma Dive Deep Dive // Emerging biotech Biotech IPOs are the industry’s lifeblood. TechTarget, Inc.s

Vaccines 40

Vaccines Adverse Reactions Drug Pricing Pharmaceutical Companies 40

pharmaphorum

JUNE 17, 2025

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 52

BioPharma Dive

JULY 9, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Merck to buy Verona and its lung drug in $10B deal The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.

Drug Pricing 111

Drug Pricing Labelling Pharmaceutical Companies Pharmaceutical Companies 111

BioPharma Dive

JUNE 9, 2025

By Ned Pagliarulo • June 4, 2025 George Frey/Reuters Deep Dive A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology Over the past 10 years, PD1-blocking medicines have transformed cancer care. You can unsubscribe at anytime. By Jonathan Gardner • Sept. By Jonathan Gardner • Sept. TechTarget, Inc.s

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

Pharmaceutical Commerce

JULY 10, 2025

Jacqueline Durett Few times in the evolution of a pharmaceutical company are as exciting as during the flurry of launch readiness activities focused on bringing a new drug to market.

Communication 64

Communication Drug Pricing Medical Schools Hospitals 64

Pharmaceutical Technology

JUNE 30, 2025

Miranda McLaren June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook When Donald Trump was elected the 47 th president of the United States of America, the outlook for pharmaceuticals was unclear, with 55% of North American industry professionals expecting negative repercussions when surveyed by GlobalData later that month.

Health and Personal Care Stores 52

Health and Personal Care Stores Packaging Drug Pricing Pharmaceutical Manufacturing 52

Pharmaceutical Technology

JUNE 27, 2025

Compounded GLP-1RAs have completely disrupted pricing frameworks for Wegovy and Mounjaro, what happens now? Robert Barrie June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The list price for a month’s supply of 2.4mg Wegovy – the drug’s highest does – is $1,350 in the US, whereas the same dose in the UK costs £175.80

Drug Pricing 59

Drug Pricing Compounding Packaging Communication 59

BioPharma Dive

JUNE 11, 2025

And though Roche and Bristol Myers acquired both their medicines in high-priced acquisitions, they haven’t yielded significant sales: Rozlytrek generated about 134 million Swiss francs in 2024 , while Augtyro pulled in just $38 million. Informa PLCs registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales.

Drug Pricing 108

Drug Pricing Immunization Immunity Drug Development 108

BioPharma Dive

JULY 10, 2025

Editors picks George Frey/Reuters Deep Dive A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology Over the past 10 years, PD1-blocking medicines have transformed cancer care. 4, 2024 Adeline Kon / BioPharma Dive/BioPharma Dive Deep Dive // Patent thickets Drug patents protect pharma profits.

Drug Pricing 88

Drug Pricing Vaccines Pharmaceutical Companies Pharmaceutical Companies 88

Pharmaceutical Technology

JUNE 10, 2025

Go deeper with GlobalData Reports United States of America (USA) Drug Pricing and Reimbursement Lands. He noted that these conflicts of interest continue to the current day, with ACIP members receiving substantial funding from pharmaceutical companies. Data Insights The gold standard of business intelligence.

Vaccines 52

Vaccines Insurance Coverage and Processing Drug Pricing Immunization 52

Pharmaceutical Technology

JUNE 18, 2025

More specifically, the Indian Pharmaceutical Alliance, an organisation representing the country’s largest pharmaceutical companies, has urged the government to reduce import tariffs from the current 10% to zero for pharmaceutical imports from the US.

Drug Pricing 52

Drug Pricing Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Commerce

JUNE 13, 2025

The Trump Administration has revived the most-favored nation (MFN) drug pricing model as a seven-year test, which would tie US drug prices to the lowest prices paid by certain OECD countries—an approach previously blocked by courts. Concerns over price controls. What is MFN model pricing? China wins?

Drug Pricing 59

Drug Pricing Biosimilars Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

JULY 9, 2025

Earlier this year, Irish medical and pharmaceutical exports to the US saw a significant surge, with a year-on-year increase above 450% in February 2025, according to data released on 15 April and reported by Reuters. How will RFK Jr’s American dream for vaccines play out?

Packaging 64

Packaging Hospitals Communication Drug Pricing 64